Jade Biosciences JBIO
NASDAQ JBIO
$14.27 +0.09 (+0.60%)
As of: Sep 30, 2026 · 1:38 PM EDT

Jade Biosciences, Inc. (JBIO) Receivables - Accured (2021 - 2024)

Updated

Jade Biosciences' Receivables - Accured came in at $300,000 for Q1 2024, unchanged from $300,000 a year earlier and down 50.0% from the prior quarter.

Analysis

Jade Biosciences, Inc. (JBIO) Receivables - Accured (2021 - 2024) Analysis & Trends

At the end of FY2023, Jade Biosciences' Receivables - Accured was $600,000, up 100.0% from FY2022.

  • Going back by year, Receivables - Accured was $300,000 in FY2022 (+200.0%) and $100,000 in FY2021.
  • The five-year range for quarterly Receivables - Accured is $100,000 (Q2 2021) to $600,000 (Q4 2023).
  • Year-over-year, Receivables - Accured increased in four of the last five quarters, with growth averaging 160.0%.
  • Business Quant data shows JBIO's Receivables - Accured at $600,000 (Q4 2023), $400,000 (Q3 2023) and $500,000 (Q2 2023) in the three quarters before Q1 2024.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 300,000.00
Dec 31, 2023 600,000.00
Sep 30, 2023 400,000.00
Jun 30, 2023 500,000.00
Mar 31, 2023 300,000.00
Dec 31, 2022 300,000.00
Sep 30, 2022 100,000.00
Mar 31, 2022 100,000.00
Dec 31, 2021 100,000.00
Jun 30, 2021 100,000.00
API Access

Jade Biosciences, Inc. Receivables - Accured API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-accured&ticker=JBIO&period=max&api_key=YOUR_API_KEY